Hyderabad, April 22, 2025 : Malla Reddy Narayana Hospital, Hyderabad is a
premier cancer care centre in Telangana, announced a remarkable medical
achievement: the successful
treatment of a rare case of Primary
Peritoneal Ewing’s Sarcoma using an advanced procedure involving Cytoreductive
Surgery (CRS) followed by Hypothermic Intraperitoneal Chemotherapy (HIPEC).
This rare and
complex case involved 24-year-old Mr. Kumar,
who had previously undergone two lines of chemotherapy at other institute came
to the Cancer Center of Malla Reddy Narayana Hospital, he was diagnosed with Primary Peritoneal Ewing’s Sarcoma, an exceptionally rare and aggressive malignancy that typically
does not occur in the peritoneum. The diagnosis and
subsequent treatment required a high level of expertise and precision, provided
by a multidisciplinary oncology team led
by Dr. Harish Dara, Senior Consultant – Surgical Oncology.
The surgical team undertook a challenging 16-hour procedure, which included complete tumor debulking followed
by the direct infusion of heated chemotherapy into the abdominal
cavity—a technique known as HIPEC.
This innovative method is designed to eradicate any residual microscopic cancer
cells, enhance chemotherapy absorption, and minimize damage to healthy tissues.
HIPEC, now available at Malla Reddy Narayana Cancer Hospital,
represents a significant advancement in the treatment of abdominal cancers such
as ovarian, colorectal, gastric cancers, pseudomyxoma peritonei, mesothelioma,
and certain rare sarcomas. Unlike conventional
chemotherapy, HIPEC is delivered intra-operatively at elevated temperatures, significantly improving
clinical outcomes.
This successful case exemplifies the hospital’s ability
to manage rare and complex
oncological conditions through advanced medical technology, surgical
expertise, and a patient-centric approach.
Quotes and Commentary
Dr. Harish Dara, Senior Consultant, Surgical Oncology, commented:
“This case represents the best of surgical innovation and team collaboration. When combined with
complete cytoreduction, HIPEC can offer patients a real chance at long-term survival
in
situations where traditional treatment
options fall short.”
Dr. G. Narendra
Prakash, Senior Anaesthetist, shared:
“The success of
this high-risk surgery required seamless coordination across multiple
departments. Intraoperative stability
was critical, and we ensured
continuous monitoring and management throughout the extended
duration of the procedure.”
Dr. Ch. Bhadra
Reddy, Chairman, Malla Reddy Vishwavidyapeeth, stated:
“This extraordinary case reflects our ongoing mission to bring
advanced and accessible cancer care to the region. We continue to invest in infrastructure, technology, and expertise that allow
us to manage even the rarest and most challenging cases with confidence and
care.”
Dr. Ch. Preethi
Reddy, Vice-Chairman, Malla Reddy Vishwavidyapeeth, stated:
“Treating Primary Peritoneal Ewing’s Sarcoma with advanced HIPEC is extremely rare—both globally and in India—due to the rarity of the
disease and the specialized nature of the treatment. It demands highly skilled
surgeons, specialized infrastructure, and a dedicated multidisciplinary team.
Malla Reddy Narayana Cancer Hospital stands among
India’s leading
advanced cancer centres.
We are proud to announce
this success and I sincerely
appreciate the commitment and
excellence of our team of doctors.”
About Malla Reddy
Narayana Cancer Hospital
Located in Suraram, Hyderabad, Malla Reddy Narayana Cancer Hospital is a state-of-the-art oncology
centre offering comprehensive cancer care. Through advanced diagnostics, expert
multidisciplinary teams, and cutting-edge treatments such as HIPEC,
the hospital remains
at the forefront of
personalized, precision-driven cancer therapy.
For more information, please contact:
• Malla Reddy Narayana
Cancer Hospital, Suraram,
Hyderabad
• Website: www.mallareddynarayana.com
• Toll-Free: 87903 87903